Tell Us What You Think

Rate your Quintiles.com experience

Subscribe to Email Based on Your Interests

Set preferences

Information Library

Primary Care

To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.

See all

  • Sort by: Most Recent
  • Title
  • INNOVEX AND HEALTHCARE AT HOME ANNOUNCE JOINT VENTURE


    September 29, 2009 - Innovex, a Quintiles company, and Healthcare at Home today announced that they have agreed to form an innovative healthcare joint venture in Europe, named Healthcare at Home Europe.

  • Grown-up thinking to mature product sales

    August 13, 2009
    This study looks at how Roche Italy decided to support the maturing end of their portfolio. And how, by rejecting traditional co-promotion, they found a much more radical, cost effective and successful solution.

  • Incremental Cost of Otitis Media Among Children in the United States

    June 25, 2009
    Using a nationally representative data source, the study estimates the medical cost of treating otitis media among children in the US. The costs are estimated at $2 billion in 2005.

  • Medicare Part D’s Effect On Prescribing Volume

    June 25, 2009
    Poster presented during the ISPOR 14th Annual International Meeting 2009 (International Society for Pharmacoeconomics and Outcomes Research) titled “Medicare Part D’s Effect On Prescribing Volume: Average Monthly Utilization of Selected High Use Drugs In The Six Protected Classes, By Different Specialties.”

  • Launching a Successful Brand in a Genericized Market

    March 27, 2009
    The market for this particular category of muscle relaxants was owned by 10 mg tablets, both branded and generic. Our customer wanted to launch a 5 mg tablet that – contrary to physician and pharmacist preconceptions – was fully as effective as the 10 mg version.

  • Training Multiple Levels of Field Staff

    March 24, 2009
    Learn about the customer situation, critical issues, the Innovex solution and results.

  • Boosting Market Share

    March 24, 2009
    Learn about the customer situation, critical issues, the Innovex solution and results.